Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report
The third Human Challenge Trial Meeting brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from Low- and Middle-Income Countries.
Controlled human infection models (CHIMs) can be helpful to study pathogenesis and for the development of vaccines. As challenge agents are used to infect healthy volunteers, ethical considerations include that the challenge studies need to be safe and results...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Accepted manuscript, 422.8KB)
- Publisher copy:
- Pubs id:
- Local pid:
- Deposit date:
- Copyright date:
- Rights statement:
- © 2020 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.biologicals.2020.04.004
If you are the owner of this record, you can report an update to it here: Report update to this record